GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Total Assets

InhaleRx (ASX:IRX) Total Assets : A$0.71 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Total Assets?

InhaleRx's Total Assets for the quarter that ended in Dec. 2024 was A$0.71 Mil.

During the past 12 months, InhaleRx's average Total Assets Growth Rate was -40.00% per year. During the past 3 years, the average Total Assets Growth Rate was 51.40% per year. During the past 5 years, the average Total Assets Growth Rate was 21.60% per year.

During the past 9 years, InhaleRx's highest 3-Year average Total Assets Growth Rate was 64.90%. The lowest was -45.50%. And the median was -21.80%.

Total Assets is connected with ROA %. InhaleRx's annualized ROA % for the quarter that ended in Dec. 2024 was -145.90%. Total Assets is also linked to Revenue through Asset Turnover. InhaleRx's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

InhaleRx Total Assets Historical Data

The historical data trend for InhaleRx's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Total Assets Chart

InhaleRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only 1.91 2.95 2.29 1.58 0.71

InhaleRx Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.29 1.12 1.58 0.58 0.71

InhaleRx Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

InhaleRx's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=-0.064+0.776
=0.71

InhaleRx's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=-0.064+0.776
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InhaleRx  (ASX:IRX) Total Assets Explanation

Total Assets is connected with ROA %.

InhaleRx's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=-0.944/( (0.582+0.712)/ 2 )
=-0.944/0.647
=-145.90 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

InhaleRx's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (0.582+0.712)/ 2 )
=0/0.647
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

InhaleRx Total Assets Related Terms

Thank you for viewing the detailed overview of InhaleRx's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Total Assets
Comparable Companies
ASX:UCM ASX:ADRDA ASX:AT1 ASX:CBL ASX:HMD ASX:LDX ASX:UBI ASX:OSL ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH STE PODD
Traded in Other Exchanges
N/A
Address
C/- Prime Company Compliance, 505 Little Collins Street, Level 9, Melbourne, VIC, AUS, 3000
Website
https://www.inhalerx.com.au
InhaleRx Ltd is an Australian biotechnology company specialising in precision medicine delivered through inhalation. Its novel drug device combinations target the treatment of BTcP and PD to help improve the quality of life of sufferers of these diseases. The medications are being developed to be delivered via a pressurised metered dose inhaler (pMDI) in a fixed dose, providing a convenient and effective mode of administration. The company's clinical pipeline comprises IRX211, a THC-based synthetic cannabinoid derived drug (dronabinol) delivered via a pMDI in a fixed dose designed to provide rapid onset analgesia for patients suffering from acute episodic bursts of breakthrough pain; and IRX616a, for the treatment of panic disorders.

InhaleRx Headlines

No Headlines